IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.960
EU - Europa 10.182
AS - Asia 5.207
AF - Africa 35
SA - Sud America 29
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 20
Totale 34.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.901
PL - Polonia 3.885
CN - Cina 2.656
UA - Ucraina 2.067
DE - Germania 1.255
SG - Singapore 985
IT - Italia 971
HK - Hong Kong 658
FI - Finlandia 554
GB - Regno Unito 462
IE - Irlanda 363
TR - Turchia 337
IN - India 204
VN - Vietnam 190
FR - Francia 186
CZ - Repubblica Ceca 93
RU - Federazione Russa 77
SE - Svezia 77
ID - Indonesia 62
ES - Italia 59
CA - Canada 46
BE - Belgio 40
IR - Iran 33
NL - Olanda 31
AU - Australia 19
EU - Europa 19
MU - Mauritius 16
JP - Giappone 13
MA - Marocco 11
KR - Corea 9
CH - Svizzera 8
CL - Cile 8
PH - Filippine 8
CU - Cuba 7
RO - Romania 7
TW - Taiwan 7
AR - Argentina 6
LT - Lituania 6
PE - Perù 6
IL - Israele 5
AZ - Azerbaigian 4
BD - Bangladesh 4
BR - Brasile 4
GE - Georgia 4
GR - Grecia 4
LK - Sri Lanka 4
NO - Norvegia 4
PK - Pakistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
EG - Egitto 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
MX - Messico 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
EE - Estonia 2
HR - Croazia 2
MY - Malesia 2
PA - Panama 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
SC - Seychelles 1
SL - Sierra Leone 1
SM - San Marino 1
TH - Thailandia 1
Totale 34.455
Salva come PNG Salva come JPEG
Città #
Warsaw 3.883
Fairfield 3.026
Woodbridge 2.187
Jacksonville 1.579
Houston 1.481
Ashburn 1.469
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.076
Wilmington 1.059
Singapore 802
Chandler 797
Princeton 669
Hong Kong 650
Nanjing 579
Beijing 481
Brescia 369
Dublin 359
Dearborn 336
New York 303
Istanbul 294
Helsinki 276
Dong Ket 181
Nanchang 180
Shenyang 147
Des Moines 144
Hebei 144
Jinan 141
San Diego 130
Changsha 126
Shanghai 116
Jiaxing 101
Lancaster 100
Milan 97
Tianjin 93
Munich 83
Boardman 77
Los Angeles 73
Kunming 71
London 66
Brno 64
San Mateo 61
Hangzhou 60
Jakarta 59
Madrid 54
San Francisco 52
Haikou 48
Verona 48
Ningbo 43
Rome 42
Augusta 40
Lanzhou 39
Zhengzhou 37
Kocaeli 35
Brussels 34
Leawood 33
Phoenix 32
Washington 31
Toronto 30
Guangzhou 29
Taizhou 28
Fuzhou 26
Kilburn 25
Ardabil 24
Norwalk 24
Olomouc 24
Changchun 23
Monmouth Junction 23
Hefei 21
Taiyuan 19
Redwood City 18
Santa Clara 15
Nürnberg 14
Orange 14
Padova 13
Amsterdam 12
Napoli 11
Pune 11
Gunzenhausen 10
Tokyo 10
Chicago 9
Falls Church 9
Ottawa 9
Wandsworth 8
Chiswick 7
Indiana 7
Ivry-sur-seine 7
La Habana 7
Melbourne 7
Pavia 7
Romola 7
Southwark 7
Boston 6
Canberra 6
Dronten 6
Markham 6
Modena 6
Rabat 6
Lima 5
Mumbai 5
Totale 27.470
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 284
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 271
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 250
The nanostructured secretome 246
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 241
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 238
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 235
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 233
Claudin3 is localized outside the tight junctions in human carcinomas 233
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 232
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 230
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 229
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 228
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 226
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 225
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 225
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 225
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 223
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 222
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 219
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 217
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 216
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 216
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 214
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 214
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 211
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 209
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 206
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 205
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 205
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 203
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 203
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 202
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 199
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 194
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 184
Zebrafish disease models in hematology: Highlights on biological and translational impact 173
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 172
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 167
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 164
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 164
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 161
Long pentraxin-3 follows and modulates bladder cancer progression 161
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 158
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 157
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 157
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 156
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 153
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 151
The zebrafish/tumor xenograft angiogenesis assay. 151
Anti-angiogenic activity of the purine analog 6-thioguanine. 151
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 147
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 146
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 146
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 143
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 142
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 141
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 141
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 141
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 139
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 135
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 134
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 133
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 133
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 131
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 131
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 131
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 130
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 129
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 127
Heparin octasaccharides inhibit angiogenesis in vivo. 127
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 126
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 126
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 126
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 125
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 125
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 124
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 124
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 124
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 123
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 123
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 123
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 122
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 122
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 121
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 120
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 120
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 120
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 120
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 120
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 119
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 119
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 119
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 119
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 118
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 117
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 117
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 116
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 115
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 115
Totale 16.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.379 0 0 0 0 0 1.174 1.128 1.067 781 1.235 455 539
2020/20216.021 181 641 232 709 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20251.785 86 57 40 861 652 89 0 0 0 0 0 0
Totale 35.184